MGLDX | MGLIX | MGLDX / MGLIX | |
Total Expense Ratio | 1.94 | 0.94 | 206% |
Annual Report Gross Expense Ratio | 1.95 | 0.95 | 205% |
Fund Existence | 10 years | 16 years | - |
Gain YTD | 2.096 | 2.494 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.29B | 2.29B | 100% |
Annual Yield % from dividends | 1.17 | 2.53 | 46% |
Returns for 1 year | 2.38 | 3.42 | 69% |
Returns for 3 years | -11.96 | -9.29 | 129% |
Returns for 5 years | 5.77 | 11.20 | 51% |
Returns for 10 years | 9.32 | 32.20 | 29% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HSMBX | 36.02 | N/A | N/A |
Horizon Multi-Factor Small/Mid Cap Adv | |||
PSSJX | 21.66 | N/A | N/A |
Principal SmallCap S&P 600 Index J | |||
JFNCX | 54.88 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
SIECX | 12.14 | N/A | N/A |
Saratoga International Equity C | |||
TEOIX | 9.14 | N/A | N/A |
Transamerica Emerging Markets Eq I |